Clinical Trials
13 trialsNCT07071961 2026-06-05
Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]
M.D. Anderson Cancer Center
Phase 2 Suspended
NCT06102902 2026-06-03
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
National Cancer Institute (NCI)
Phase 1 Suspended
NCT06130826 2026-06-03
Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer
City of Hope Medical Center
Phase 1 Suspended
NCT03722680 2026-05-20
RILUZOX-01
UNICANCER
Phase 2 Suspended
NCT05200442 2026-05-08
A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer
University of Chicago
Phase 1/2 Suspended
NCT06653010 2026-05-07
Wondercel-UWD1
Wondercel Biotech (ShenZhen)
Phase EARLY_PHASE1 Suspended
NCT06675513 2026-05-07
Autologous CAR-T Cells (WD-01) for Metastatic Colorectal Cancer
Wondercel Biotech (ShenZhen)
Phase EARLY_PHASE1 Suspended
NCT05241210 2025-12-09
Real-Time Feedback (RTFB) to Improve Colonoscopy
University of Minnesota
Phase NA Suspended
NCT04392050 2025-11-28
A Community-Based Educational Intervention to Improve Colorectal Cancer Screening
Thomas Jefferson University
Suspended
NCT05400122 2025-11-12
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
Case Comprehensive Cancer Center
Phase 1 Suspended
NCT04693546 2025-09-26
PREVENT
Metabiomics Corp
Suspended
NCT04031469 2025-07-31
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
ProgenaBiome
Suspended
NCT05958199 2025-06-27
A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7
NextPoint Therapeutics, Inc.
Phase 1 Suspended